- Sort by date
- Hybrid Sort
- Sorted by Smart Random Sort
- Sort by relevance
Advertisements
» Related Searches: cancer, lung cancer treatment, prostate cancer, cancer risk, breast cancer
Results 11 to 20 of 48 
Watchdog rules against new treatment for lung cancer
Thousands of lung cancer sufferers are set to be denied the drug Tarceva, under draft
guidance from health watchdog … 
- ├ ENGLAND WON'T GET LUNG DRUG — Mirror.co.uk - 3am - 3am Content
- ├ Lung cancer top killer among malignant tumors … — KeralaNext: China
- ├ Nab-Paclitaxel and Carboplatin Appear Effective in Lung … — Medscape Hematology-Oncology Headlines
- └ all 10 related »
Blow Smoke Rings without Getting that Nasty Lung-Cancer
The Zero Blaster is a new toy that encourages kids to blow smoke rings, but with a
gun—not cigarettes. The Zero Blaster includes a light for fun at day or …
- ├ NICE disapproves the use of cancer drug Tarceva — The Earth Times Online Newspaper
- ├ Roswell signs for lung cancer registry — Latest news from Business First of Buffalo
- ├ Lung Carcinogenesis Tracked By DNA Methylation Mapping … — ScienceDaily Headlines
- └ all 10 related »
Nab-Paclitaxel and Carboplatin Appear Effective in Lung Cancer
A new formulation of paclitaxel followed by carboplatin is showing promise in the
first-line treatment of advanced non?small-cell lung cancer. Medscape Medical News
Allison Gandey …
- ├ Adding Bevacizumab to First-Line Lung Cancer Therapy … — Medscape Headlines
- ├ Ovarian Cancer Studies Elusive: Should Erlotinib Be … — Medscape Hematology-Oncology Headlines
- ├ Vaccination With Embryonic Stem Cells Prevents Lung … — Health News from Medical News Today
- └ all 10 related »
Lung Carcinogenesis Tracked By DNA Methylation Mapping In Exhaled Breath …
… lung cancer patients, suggesting that, in theory, it may be possible to use this
technique to identify people who have undiagnosed lung cancer or are at high risk of
developing …
- ├ Scientists Developing Lung Cancer Breath Test (HealthDay) … — UNTITLED FEED
- ├ Breath Test help to predict Lung Cancer; … — KeralaNext: Health
- ├ Scientists Developing Lung Cancer Breath Test — MedicineNet Daily News
- └ all 10 related »
Vaccination With Embryonic Stem Cells Prevents Lung Cancer In Mice
… lung cancer in those animals that had had cancer cells transplanted into
them after the vaccination or that had been exposed to cancer-causing chemicals.
[click link for full article] …
- ├ Scientists Create Artificial Liver From Stem Cells — RedOrbit News - Science
- ├ Adult Stem Cells Have Ability to Develop … — ArriveNet : Health
- ├ Stem cells give hope for diabetes cure — NewKerala Health News
- └ all 10 related »
Scientists Developing Lung Cancer Breath Test (HealthDay)
A simple breath test could someday help predict who's at highest risk of getting lung
cancer …
- ├ Breast Cancer Diagnosis Brings Serious Distress (HealthDay) … — Yahoo! News: Health News
- ├ Jefferson scientists find blood vessel-building protein halts … — EurekAlert! - Biology
- └ all 10 related »
Crown princess' ailing father has no regrets
… lung cancer …
- ├ Henry: No regrets over Barca 'snub' — FOXSports.com News for FOX SOCCER
- ├ Princess Royal opens winchhouse — BBC News | Scotland | UK Edition
- ├ Princess Royal to open winchhouse — BBC News | Scotland | UK Edition
- └ all 10 related »
NICE rejects use of cancer drug Tarceva
Tarceva, a lung cancer drug manufactured by Roche, may not be approved in the UK
following a negative recommendation by the National Institute for Health and Clinical
Excellence …
- ├ NICE consults on advice on two treatments … — OnMedica Latest News
- ├ NICE refuse to fund life-prolonging cancer drug … — the Mail online | Health
- ├ NICE refuses to fund life-prolonging cancer drug … — the Mail online | Health
- └ all 10 related »
Around 200 die each year from radon gas - institute
… lung cancer as a result of exposure, according to the Radiological Protection
Institute of Ireland (RPII) …
Pharmion buys Cabrellis for $59 million
Pharmion Corporation has purchased private oncology company Cabrellis, which holds the US
and EU rights to lung cancer drug amrubicin, for $59 million …